TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Inner-City Anti-IgE Therapy for Asthma (ICAC-08)
Brief Summary: The purpose of this study is to find out if adding omalizumab to standard asthma treatment results in a safer, more effective, and longer lasting asthma treatment strategy than standard treatment alone, in inner-city children with mild to severe asthma.


Options:
A: Arm Label: Omalizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Omalizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Omalizumab; Assigned to Arm(s): Omalizumab | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
B: Arm Label: Omalizumab (Xolair) + Conventional Therapy; Type: EXPERIMENTAL; Interventions: Biological: omalizumab | Arm Label: Placebo + Conventional Therapy; Type: PLACEBO_COMPARATOR; Interventions: Biological: omalizumab placebo | Intervention Type: BIOLOGICAL; Name: omalizumab; Assigned to Arm(s): Omalizumab (Xolair) + Conventional Therapy | Intervention Type: BIOLOGICAL; Name: omalizumab placebo; Assigned to Arm(s): Placebo + Conventional Therapy
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: lebrikizumab (MILR1444A) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: lebrikizumab (MILR1444A); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
D: Arm Label: MEDI528 0.3 mg/kg; Type: EXPERIMENTAL; Interventions: Biological: MEDI528 0.3 mg/kg | Arm Label: MEDI528 1 mg/kg; Type: EXPERIMENTAL; Interventions: Biological: MEDI528 1 mg/kg | Arm Label: MEDI528 3 mg/kg; Type: EXPERIMENTAL; Interventions: Biological: MEDI528 3 mg/kg | Arm Label: PLACEBO; Type: PLACEBO_COMPARATOR; Interventions: Other: PLACEBO | Intervention Type: BIOLOGICAL; Name: MEDI528 0.3 mg/kg; Assigned to Arm(s): MEDI528 0.3 mg/kg | Intervention Type: BIOLOGICAL; Name: MEDI528 1 mg/kg; Assigned to Arm(s): MEDI528 1 mg/kg | Intervention Type: BIOLOGICAL; Name: MEDI528 3 mg/kg; Assigned to Arm(s): MEDI528 3 mg/kg | Intervention Type: OTHER; Name: PLACEBO; Assigned to Arm(s): PLACEBO

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Inner-City Anti-IgE Therapy for Asthma (ICAC-08)
Brief Summary: The purpose of this study is to find out if adding omalizumab to standard asthma treatment results in a safer, more effective, and longer lasting asthma treatment strategy than standard treatment alone, in inner-city children with mild to severe asthma.


Options:
A: Arm Label: Reference Strategy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Inhaled corticosteroids | Arm Label: Biomarker Strategy; Type: EXPERIMENTAL; Interventions: Drug: Inhaled corticosteroids, Procedure: eNO measurement | Intervention Type: DRUG; Name: Inhaled corticosteroids; Assigned to Arm(s): Biomarker Strategy, Reference Strategy | Intervention Type: PROCEDURE; Name: eNO measurement; Assigned to Arm(s): Biomarker Strategy
B: Arm Label: Omalizumab (Xolair) + Conventional Therapy; Type: EXPERIMENTAL; Interventions: Biological: omalizumab | Arm Label: Placebo + Conventional Therapy; Type: PLACEBO_COMPARATOR; Interventions: Biological: omalizumab placebo | Intervention Type: BIOLOGICAL; Name: omalizumab; Assigned to Arm(s): Omalizumab (Xolair) + Conventional Therapy | Intervention Type: BIOLOGICAL; Name: omalizumab placebo; Assigned to Arm(s): Placebo + Conventional Therapy
C: Arm Label: Two Step Hand-Hygiene; Type: EXPERIMENTAL; Interventions: Other: Active Hand Sanitizer | Arm Label: Usual Care Hand Hygiene; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Active Hand Sanitizer; Assigned to Arm(s): Two Step Hand-Hygiene
D: Arm Label: Omalizumab; Type: EXPERIMENTAL; Interventions: Biological: Omalizumab, Biological: Placebo fluticasone | Arm Label: Inhaled Corticosteroid Boost Therapy (ICS); Type: EXPERIMENTAL; Interventions: Drug: Inhaled Corticosteroid Boost Therapy (ICS), Biological: Placebo omalizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo omalizumab, Biological: Placebo fluticasone | Intervention Type: BIOLOGICAL; Name: Omalizumab; Assigned to Arm(s): Omalizumab | Intervention Type: DRUG; Name: Inhaled Corticosteroid Boost Therapy (ICS); Assigned to Arm(s): Inhaled Corticosteroid Boost Therapy (ICS) | Intervention Type: BIOLOGICAL; Name: Placebo omalizumab; Assigned to Arm(s): Inhaled Corticosteroid Boost Therapy (ICS), Placebo | Intervention Type: BIOLOGICAL; Name: Placebo fluticasone; Assigned to Arm(s): Omalizumab, Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Internet-Based Patient-Centered Asthma Management System
Brief Summary: Asthma is a respiratory condition that affects millions of children. It can be controlled, however, with the proper medications and treatment. AsthmaNet, an internet-based asthma management system, aims to improve the asthma care of children by providing their parents and doctors with appropriate tools and feedback related to asthma management. The purpose of this study is to evaluate the effectiveness of AsthmaNet at improving quality of care and controlling asthma symptoms in children.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: AsthmaNet | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: AsthmaNet; Assigned to Arm(s): 1
B: Arm Label: Asthma Feedback; Type: EXPERIMENTAL; Interventions: Behavioral: Asthma Feedback | Arm Label: Preventive Feedback; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Asthma Feedback | Intervention Type: BEHAVIORAL; Name: Asthma Feedback; Assigned to Arm(s): Asthma Feedback, Preventive Feedback
C: Arm Label: CHESS + Case Mgt; Type: EXPERIMENTAL; Interventions: Behavioral: CHESS Internet telehealth | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: CHESS Internet telehealth; Assigned to Arm(s): CHESS + Case Mgt
D: Arm Label: Arm 1: Incentives, plus reminders & feedback (IRF); Type: EXPERIMENTAL; Interventions: Other: Nominal Financial Incentives, Other: Daily Adherence Reminders/Adherence Performance Feedback | Arm Label: Arm 2: Reminders & feedback ONLY; Type: ACTIVE_COMPARATOR; Interventions: Other: Daily Adherence Reminders/Adherence Performance Feedback | Arm Label: Arm 3 (Control); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Nominal Financial Incentives; Assigned to Arm(s): Arm 1: Incentives, plus reminders & feedback (IRF) | Intervention Type: OTHER; Name: Daily Adherence Reminders/Adherence Performance Feedback; Assigned to Arm(s): Arm 1: Incentives, plus reminders & feedback (IRF), Arm 2: Reminders & feedback ONLY

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Primary Care to Prevent Childhood Obesity
Brief Summary: To determine the extent to which a clinical intervention based on the Chronic Care Model (CCM), compared with the usual care control condition, results in a smaller age-associated increase in body mass index (BMI) over a 1 year intervention (primary outcome) and a 1 1/2-year follow-up period.


Options:
A: Arm Label: Intervention Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: face-to-face meetings and access to a website | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: face-to-face meetings and access to a website; Assigned to Arm(s): Intervention Group
B: Arm Label: A: experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity-Children | Arm Label: (B): experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity-Children | Arm Label: (c): experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity-Children | Arm Label: (D): control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Obesity-Children | Intervention Type: BEHAVIORAL; Name: Obesity-Children; Assigned to Arm(s): (B): experimental, (D): control group, (c): experimental, A: experimental
C: Arm Label: Team PLAY Group; Type: EXPERIMENTAL; Interventions: Behavioral: Team PLAY | Arm Label: Standard Care Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Team PLAY; Assigned to Arm(s): Team PLAY Group
D: Intervention Type: BEHAVIORAL; Name: To change structure and roles of primary care teams to optimize prevention of obesity; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Primary Care to Prevent Childhood Obesity
Brief Summary: To determine the extent to which a clinical intervention based on the Chronic Care Model (CCM), compared with the usual care control condition, results in a smaller age-associated increase in body mass index (BMI) over a 1 year intervention (primary outcome) and a 1 1/2-year follow-up period.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: School children and adolescents as health experts | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: School children and adolescents as health experts; Assigned to Arm(s): A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Teacher-Delivered Weight Control Intervention | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Teacher-Delivered General Health Intervention | Intervention Type: BEHAVIORAL; Name: Teacher-Delivered Weight Control Intervention; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Teacher-Delivered General Health Intervention; Assigned to Arm(s): 2
C: Intervention Type: BEHAVIORAL; Name: To change structure and roles of primary care teams to optimize prevention of obesity; Assigned to Arm(s): N/A
D: Arm Label: reducing beverages and sugar and increase physical activity; Type: EXPERIMENTAL; Interventions: Behavioral: lifestyle | Arm Label: control -no intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: lifestyle; Assigned to Arm(s): reducing beverages and sugar and increase physical activity

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Primary Care to Prevent Childhood Obesity
Brief Summary: To determine the extent to which a clinical intervention based on the Chronic Care Model (CCM), compared with the usual care control condition, results in a smaller age-associated increase in body mass index (BMI) over a 1 year intervention (primary outcome) and a 1 1/2-year follow-up period.


Options:
A: Arm Label: Obesity tools in electronic health record; Type: EXPERIMENTAL; Interventions: Other: Obesity tools in the electronic health record | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Obesity tools in the electronic health record; Assigned to Arm(s): Obesity tools in electronic health record
B: Arm Label: Family Behavioral Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Family Intervention | Arm Label: Motivational Interviewing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational Interviewing | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioral Family Intervention; Assigned to Arm(s): Family Behavioral Treatment | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): Motivational Interviewing
C: Intervention Type: BEHAVIORAL; Name: To change structure and roles of primary care teams to optimize prevention of obesity; Assigned to Arm(s): N/A
D: Arm Label: Individual Telephone Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Individual telephone intervention | Arm Label: Group Telephone Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group telephone intervention | Intervention Type: BEHAVIORAL; Name: Individual telephone intervention; Assigned to Arm(s): Individual Telephone Intervention | Intervention Type: BEHAVIORAL; Name: Group telephone intervention; Assigned to Arm(s): Group Telephone Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Optimisation d'un Produit de thérapie Cellulaire Autologue Par Cellules mononucléées médullaires Dans l'ischémie Critique Des Membres inférieurs liée à l'athérosclérose
Brief Summary: This study will treat by cell therapy 20 patients with critical leg ischemia (CLI) not eligible for revascularization or angioplasty. It will use exactly the same protocol as published by Tateishi-Yuyama et al. (Lancet 2002), using bone-marrow mononuclear cells (BMMNC).


Options:
A: Arm Label: BM-MNC; Type: EXPERIMENTAL; Interventions: Procedure: BM-MNC preparation | Arm Label: PB-MNC; Type: EXPERIMENTAL; Interventions: Procedure: PB-MNC preparation | Intervention Type: PROCEDURE; Name: BM-MNC preparation; Assigned to Arm(s): BM-MNC | Intervention Type: PROCEDURE; Name: PB-MNC preparation; Assigned to Arm(s): PB-MNC
B: Arm Label: mesenchymal stem cells; Type: EXPERIMENTAL; Interventions: Drug: mesenchymal stem cells | Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Plasmalyte A | Intervention Type: DRUG; Name: mesenchymal stem cells; Assigned to Arm(s): mesenchymal stem cells | Intervention Type: DRUG; Name: Plasmalyte A; Assigned to Arm(s): Placebo
C: Intervention Type: PROCEDURE; Name: cell therapy; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intraarterial stem cell therapy, Other: Stem cells | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Procedure: intraarterial stem cell therapy, Other: Stem cells | Intervention Type: PROCEDURE; Name: intraarterial stem cell therapy; Assigned to Arm(s): 1, 2 | Intervention Type: OTHER; Name: Stem cells; Assigned to Arm(s): 1, 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Optimisation d'un Produit de thérapie Cellulaire Autologue Par Cellules mononucléées médullaires Dans l'ischémie Critique Des Membres inférieurs liée à l'athérosclérose
Brief Summary: This study will treat by cell therapy 20 patients with critical leg ischemia (CLI) not eligible for revascularization or angioplasty. It will use exactly the same protocol as published by Tateishi-Yuyama et al. (Lancet 2002), using bone-marrow mononuclear cells (BMMNC).


Options:
A: Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: ALDH-br bone marrow cells vs. mononuclear bone marrow cells | Intervention Type: PROCEDURE; Name: ALDH-br bone marrow cells vs. mononuclear bone marrow cells; Assigned to Arm(s): 2
B: Intervention Type: GENETIC; Name: Autologous bone marrow cells; Assigned to Arm(s): N/A
C: Arm Label: BM-MNC; Type: EXPERIMENTAL; Interventions: Procedure: BM-MNC preparation | Arm Label: PB-MNC; Type: EXPERIMENTAL; Interventions: Procedure: PB-MNC preparation | Intervention Type: PROCEDURE; Name: BM-MNC preparation; Assigned to Arm(s): BM-MNC | Intervention Type: PROCEDURE; Name: PB-MNC preparation; Assigned to Arm(s): PB-MNC
D: Intervention Type: PROCEDURE; Name: cell therapy; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Joint Attention Intervention in Young Children With Autism - a Randomized Study
Brief Summary: The purpose of this study is to investigate the effectiveness of an intervention aimed to increase joint attention in 2-4 year old children with autism. The study will be conducted in mainstream preschools in Norway. The intervention will be implemented by preschool teachers and paraprofessionals supervised by trained counselors.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Early intervention blending several tx approaches, w/ focus | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Early intervention blending several treatment approaches | Intervention Type: BEHAVIORAL; Name: Early intervention blending several tx approaches, w/ focus; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Early intervention blending several treatment approaches; Assigned to Arm(s): 2
B: Intervention Type: BEHAVIORAL; Name: Caregiver joint attention intervention; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Joint attention intervention; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive behavioral therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive behavioral therapy; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Joint Attention Intervention in Young Children With Autism - a Randomized Study
Brief Summary: The purpose of this study is to investigate the effectiveness of an intervention aimed to increase joint attention in 2-4 year old children with autism. The study will be conducted in mainstream preschools in Norway. The intervention will be implemented by preschool teachers and paraprofessionals supervised by trained counselors.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive behavioral therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive behavioral therapy; Assigned to Arm(s): 1
B: Intervention Type: BEHAVIORAL; Name: Joint attention intervention; Assigned to Arm(s): N/A
C: Arm Label: Caregiver Education Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Caregiver-Education Intervention | Arm Label: Caregiver-Mediated Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Caregiver-Mediated Intervention | Intervention Type: BEHAVIORAL; Name: Caregiver-Mediated Intervention; Assigned to Arm(s): Caregiver-Mediated Intervention | Intervention Type: BEHAVIORAL; Name: Caregiver-Education Intervention; Assigned to Arm(s): Caregiver Education Intervention
D: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Joint Attention Intervention in Young Children With Autism - a Randomized Study
Brief Summary: The purpose of this study is to investigate the effectiveness of an intervention aimed to increase joint attention in 2-4 year old children with autism. The study will be conducted in mainstream preschools in Norway. The intervention will be implemented by preschool teachers and paraprofessionals supervised by trained counselors.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive behavioral therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive behavioral therapy; Assigned to Arm(s): 1
B: Intervention Type: BEHAVIORAL; Name: Caregiver joint attention intervention; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Joint attention intervention; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Early intervention blending several tx approaches, w/ focus | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Early intervention blending several treatment approaches | Intervention Type: BEHAVIORAL; Name: Early intervention blending several tx approaches, w/ focus; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Early intervention blending several treatment approaches; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Open-Label, Rater Blinded Assessment of Optimal Treatment Change Strategy to Risperidone for Patients Intolerant of Olanzapine
Brief Summary: The purpose of this study is to compare three strategies for switching patients with schizophrenia or schizoaffective disorder to the atypical antipsychotic, risperdone, after they have been unsuccessfully treated with another atypical antipsychotic, olanzapine. In the second phase of this study, investigators will assess the effectiveness of behavioral therapy in reducing body weight in risperdone-treated patients who are overweight or have problems with diabetes or blood sugar.


Options:
A: Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): N/A
B: Arm Label: A1; Type: ACTIVE_COMPARATOR; Interventions: Drug: aripiprazole | Arm Label: A2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: aripiprazole; Assigned to Arm(s): A1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A2
C: Arm Label: 1. Paliperidone ER; Type: EXPERIMENTAL; Interventions: Drug: Paliperidone ER | Arm Label: 2 Risperidone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Risperidone | Intervention Type: DRUG; Name: Paliperidone ER; Assigned to Arm(s): 1. Paliperidone ER | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): 2 Risperidone
D: Intervention Type: DRUG; Name: risperidone; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Ullevål PersonalityProject. A Randomized Controlled Trial of Intensive Daytreatment Followed by Outpatient Long-term Combined Treatment Compared With Eclectic Individual Therapy for Patients With Personality Disorders
Brief Summary: Ullevål PersonalityProject is a ranomized controlled trial of treatment of patients with personality disorder. It's main purpose is to test the effect of a long-term combined treatment program compared with eclectic individual therapy for patients with personality disorders.

The main study hypothesis is that long-term combined treatment is superior to eclectic individual therapy with respect to improvement in personality functioning, psychosocial functioning, symptoms, interpersonal problems, and self destructive behavior for poorly functioning patients with personality disorders.


Options:
A: Arm Label: Body Acceptance Program; Type: EXPERIMENTAL; Interventions: Behavioral: Body Acceptance Program | Arm Label: Waitlist control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Body Acceptance Program; Assigned to Arm(s): Body Acceptance Program
B: Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): N/A
C: Arm Label: Combined psychotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: Combined psychotherapy | Arm Label: Outpatient individual psychotherapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Outpatient individual psychotherapy | Intervention Type: BEHAVIORAL; Name: Combined psychotherapy; Assigned to Arm(s): Combined psychotherapy | Intervention Type: BEHAVIORAL; Name: Outpatient individual psychotherapy; Assigned to Arm(s): Outpatient individual psychotherapy
D: Arm Label: Experimental Arm; Type: EXPERIMENTAL; Interventions: Other: Other | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Other; Assigned to Arm(s): Experimental Arm

Answer: C